Skip to main content

Q&As

ALN
February 11, 2021
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
ALN
January 07, 2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
ALN
November 18, 2020
At the 2020 Fall Clinical Dermatology Conference, Roger S. Ho, MD, MS, MPH, FAAD, presented on clinically important psoriasis comorbidities. In an interview with the Autoimmune Learning Network, he discussed what clinicians need to know about these comorbid conditions when treating patients.
Gastro Learning Network
October 27, 2020

In this Q&A, Dr Carreras-Torres, from the Bellvitge Biomedical Research Institute in Barcelona, Spain, discusses his research into factors that can increase the risk of developing, and worsen the course of existing, inflammatory bowel disease.

Gastro Learning Network
October 27, 2020

Anne Peery, MD, from the University of North Carolina, provides insight into the American Gastroenterological Association's recent update on the management of colonic diverticulitis.

Gastro Learning Network
October 27, 2020

Dr Feuerstein chaired the guideline panel that developed the American Gastroenterological Association's new guidelines on managing ulcerative colitis. He sat down with Gastroenterology Learning Network to answer a few questions.

Gastro Learning Network
October 27, 2020

Patients with inflammatory bowel disease are at increased risk for contracting vaccine-preventable diseases, yet often have lower rates of immunization than the general population. There are ways to improve these rates and protect patients, according to Freddy Caldera, DO, from the University of…

Gastro Learning Network
October 27, 2020

About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary cholangitis for rheumatoid arthritis, Sjogren syndrome, and…

The Dermatologist
October 20, 2020
A recent study showed patients with Down syndrome are more likely to develop hidradenitis suppurativa compared with individuals without Down syndrome. Corresponding author Raed Alhusayen, MBBS, MSCE, FRCPC, discussed these findings in an interview with The Dermatologist.
ALN
October 15, 2020
What is the association between depression and subsequent risk of rheumatoid arthritis by serologic phenotype? In this Q&A, Jeffrey Sparks, MD, explains.
Back to Top